Twitter | Search | |
Roche
Doing now what patients need next! Read our community guidelines here:
11,575
Tweets
1,687
Following
195,075
Followers
Tweets
Roche Aug 21
Replying to @jimaxyn
(2/2) Please get in touch with the Accu-Chek Customer Support team in the UK on 01444 256442. The team will be happy to immediately assist you in getting the diabetes management supplies you need. Kind regards, Your Roche Twitter Team.
Reply Retweet Like
Roche Aug 21
Replying to @jimaxyn
(1/2) Hello, We’re sorry to hear that you were not able to access the test strips that you and your son are used to.
Reply Retweet Like
Roche Aug 20
Replying to @disbelch
Hi David, thanks for commenting. Genomic testing is considered a relatively new and innovative technology. We're committed to bringing it to as many patients as possible and working hard to ensure affordability isn’t a barrier to access. Kind regards, Your Roche Twitter Team
Reply Retweet Like
Roche Aug 20
Replying to @teebodiesel
Hi JulioD, thanks for getting in touch. Every patient’s cancer has a unique set of DNA mutations which help to drive its growth. Cancer genomic testing can help to identify what these mutations are, and which treatments might work best. Kind regards, Your Roche Twitter Team
Reply Retweet Like
Roche Aug 20
Replying to @VeronikaSain
Hi Veronika. We realise that the cost of innovative medicines can be challenging for some healthcare systems, so we continue to work closely with them to ensure that as many people can benefit from our medicines as possible. Kind regards, Your Roche Twitter Team
Reply Retweet Like
Roche Aug 20
Replying to @Galenical
Dear Doctor, thanks for commenting. Cancer genomic testing insights mean patients can be potentially matched to precision medicines, as well as clinical trials, which otherwise may not have been possible. Kind regards, Your Roche Twitter Team
Reply Retweet Like
Roche Aug 19
Replying to @lfc4eva99
Hello Nikhil, We are very sorry to hear this. We have escalated your case to our colleagues in India who will be in touch. We appreciate your patience in the matter. Kind regards, Your Roche Twitter Team.
Reply Retweet Like
Roche Aug 17
Replying to @Roche
The correct answer is >20 – NTRK gene fusions have been found in many different types of adult and paediatric cancers. This highlights the importance of gene testing, to identify the correct targeted therapy for a patient’s cancer.
Reply Retweet Like
Roche Aug 16
We are proud to announce that our treatment for ROS1-positive non-small cell and NTRK gene fusion-positive solid is now approved in the US. Find out more:
Reply Retweet Like
Roche Aug 16
that >30% of patients with non-small cell could develop brain metastases during the course of their disease? ROS1-positive NSCLC occurs when a ROS1 gene fusion takes place, causing cancer cells to grow and proliferate.
Reply Retweet Like
Roche Aug 16
Certain fusions in our genes can drive cancer growth across a number of tumour types, regardless of where they are found in the body. Do you know in how many different types of cancer NTRK gene fusions are found?
Reply Retweet Like
Roche Aug 16
First tumour-agnostic medicine for the treatment of both ROS1-positive non-small cell and NTRK gene fusion-positive solid approved in the US. Learn more:
Reply Retweet Like
Roche Aug 16
At Roche, we are leading the way in personalised cancer medicine, utilising advanced genomic testing to identify treatments that target the unique genetic make-up of a person’s cancer, regardless of its location in the body. Read more here:
Reply Retweet Like
Roche Aug 16
We are delighted to announce the FDA approval of the first tumour-agnostic medicine for ROS1-positive non-small cell and NTRK gene fusion-positive solid . Read more:
Reply Retweet Like
Roche Aug 14
Replying to @lfc4eva99
(2/2) We’re sorry to hear that you’re disappointed with the service you have received. We appreciate your feedback and we have shared this with the team. We hope that you will be happy with the replacement device. Kind regards, Your Roche Twitter Team.
Reply Retweet Like
Roche Aug 14
Replying to @lfc4eva99
(1/2) Hello, Thanks for getting back to us. We’ve spoken to our AccuChek colleagues in India who have confirmed that a replacement was delivered on 12 August. A member of the team tried to contact you on 13 August. As they couldn’t speak to you, they’ll try again.
Reply Retweet Like
Roche Aug 13
More than 50% of people aren’t familiar with cancer , despite the fact it could help inform personalised treatment. We’re driving awareness of testing and how it can impact patients. Read Jamal and Debbie’s stories:
Reply Retweet Like
Roche Aug 12
Spinal Muscular Atrophy affects people at any age, from childhood to adulthood. RT to raise awareness this .
Reply Retweet Like
Roche Aug 9
Replying to @lfc4eva99
We are very sorry to hear about your experience. We have reached out to our colleagues in India to find the right person to get in touch with you. We appreciate your understanding and thank you for your patience in the matter. Kind regards, Your Roche Twitter Team.
Reply Retweet Like
Roche Aug 9
Replying to @katsdd
Hello Kimmie, Thanks for reaching out. For more information about the availability of Eversense in Canada, please get in touch with your local Roche affiliate in Canada. You can find the contact details here: Kind Regards, Your Roche Twitter team
Reply Retweet Like